At PODD, a leading forum covering cutting-edge scientific and business trends in drug delivery, Bernd Mahlmann of Ypsomed and Daniele Tartini of SCHOTT Pharma will present how patient data and drug requirements inform the design of a large-volume autoinjector and syringe. From injection time to tolerability, their talk explores how real-world inputs shaped a 5.5 mL device concept.
YpsoFlow, our spring-driven pre-filled pen platform which is powering momentum and driving access to GLP-1 markets, will also be on display, alongside a first look at what’s next in sustainable self-injection...
Our speakers at the conference
Bernd Mahlmann
Bernd Mahlmann, Executive MBA, is a senior business development executive with over 15 years of experience in the international pharmaceutical and medical device industries. He specializes in driving customer-centric transformation and supporting strategic growth. At Ypsomed, he focuses on advising pharmaceutical partners in selecting optimal drug delivery systems tailored to their therapeutic assets—ensuring effective treatment outcomes and improved patient experience. Bernd combines strategic insight with hands-on expertise to support companies navigate complex challenges and seize growth opportunities across global markets.
